STOCKWATCH
·
Pharmaceuticals
New Launch13 Jun 2025, 08:52 am

Sigachi Industries Secures Terms of Reference (ToR) Approval for its Upcoming API and Specialty Chemicals Manufacturing Facility in Orvakal, Andhra Pradesh

AI Summary

Sigachi Industries Limited, a leading player in pharmaceutical excipients and active ingredients, has received the Terms of Reference (ToR) from the State Environment Impact Assessment Authority (SEIAA), Andhra Pradesh for its upcoming Bulk Drugs, Drug Intermediates, and Specialty Chemicals facility at Orvakal, Kurnool District. This strategic project is proposed over 25.09 acres at Plot No. A-10, Guttapadu-Orvakal Node and will enhance the company’s API manufacturing capacity and global reach, support pipeline expansion for regulated and semi-regulated markets, establish a strategically located facility with export potential, and contribute to ‘Make in India’ through world-class infrastructure and sustainable practices.

Key Highlights

  • Sigachi Industries Limited has received Terms of Reference (ToR) approval for its upcoming Bulk Drugs, Drug Intermediates, and Specialty Chemicals facility at Orvakal, Kurnool District, Andhra Pradesh.
  • The facility is proposed over 25.09 acres and falls under Category B1, aligned with Schedule 5(f) of the EIA Notification, 2006, applicable to the Synthetic Organic Chemicals sector.
  • The Terms of Reference approval marks the beginning of the Environmental Clearance (EC) process from 15th July 2025, followed by project development activities from 1st August 2025.
  • The new facility will strengthen Sigachi's product supply chain, enable faster commercialization, seamless tech transfers, and enhanced responsiveness to evolving customer requirements.
  • Sigachi Industries Limited is a global player in the pharmaceutical industry dedicated to pioneering advancements in Active Pharmaceutical Ingredients (APIs), Intermediates, Excipients, vitamin-mineral blends, and Operations and Management (O&M) services.
SIGACHI
Pharmaceuticals
Sigachi Industries Ltd

Price Impact